Loading...
•
Jun 30, 2025
HCA Q2 2025 Earnings Report
HCA Q2 2025 Earnings Report showed strong revenue growth, higher net income, and raised full-year guidance.
Key Takeaways
HCA Healthcare delivered solid Q2 2025 results with revenue and net income growth driven by improved margins and higher admissions, while also raising full-year guidance.
Revenue rose to $18.61B, up from $17.49B last year
Net income increased to $1.65B, reflecting improved margins
EPS reached $6.83; adjusted EPS $6.84
Raised full-year 2025 guidance for revenue, net income, and EPS
Forward Guidance
HCA raised its 2025 full-year guidance, reflecting confidence in continued revenue growth and stable operating conditions.
Positive Outlook
- Raised revenue guidance to $74B-$76B
- Raised net income guidance to $6.11B-$6.48B
- Raised adjusted EBITDA guidance to $14.7B-$15.3B
- Raised diluted EPS guidance to $25.50-$27.00
- Stable operating environment expected
Challenges Ahead
- Assumes ongoing impact from 2024 hurricanes
- Potential inflationary pressures
- Uncertainty in healthcare policy developments
- Possible tariff and trade-related cost pressures
- No change to capital expenditure forecast of $5B
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...